Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Filgotinib 200 mg	945
Overall Study	STARTED	Filgotinib 100 mg	119
Overall Study	STARTED	Placebo	124
Overall Study	Treated	Filgotinib 200 mg	944
Overall Study	Treated	Filgotinib 100 mg	119
Overall Study	Treated	Placebo	124
Overall Study	COMPLETED	Filgotinib 200 mg	0
Overall Study	COMPLETED	Filgotinib 100 mg	0
Overall Study	COMPLETED	Placebo	0
Overall Study	NOT COMPLETED	Filgotinib 200 mg	945
Overall Study	NOT COMPLETED	Filgotinib 100 mg	119
Overall Study	NOT COMPLETED	Placebo	124

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02914600/flow